4th edition of Vaccines Summit Boston 2024 (VSBOSTON24)
| When | Tuesday, June 18, 2024 - Thursday, June 20, 2024 |
| Where | Boston United States |
| Category | Vaccine |
| Location | |
| Organised by | Biogate Scientific Center |
| Share this page: |  |
 |
 |
 |
About the event
The Vaccines Summit Boston is an esteemed annual event dedicated to bringing together leading experts, researchers, policymakers, industry professionals, and stakeholders from around the world to discuss and collaborate on important aspects of vaccines and immunization. The upcoming Vaccines Summit Boston 2024 will mark its fourth edition and is anticipated to be an insightful and impactful gathering. VSBOSTON24 aims to provide a platform for sharing knowledge, research findings, and innovative approaches in the field of vaccines. It will serve as a forum for engaging in discussions, exploring emerging trends, and addressing critical challenges faced by the global healthcare community.
The Vaccines Summit Boston is an esteemed annual event dedicated to bringing together leading experts, researchers, policymakers, industry professionals, and stakeholders from around the world to discuss and collaborate on important aspects of vaccines and immunization. The upcoming Vaccines Summit Boston 2024 will mark its fourth edition and is anticipated to be an insightful and impactful gathering. VSBOSTON24 aims to provide a platform for sharing knowledge, research findings, and innovative approaches in the field of vaccines. It will serve as a forum for engaging in discussions, exploring emerging trends, and addressing critical challenges faced by the global healthcare community.
Sessions / Tracks
- Vaccine Immunology
- Vaccine Development & Design
- Vaccine Safety & Adverse Events
- Vaccine Trials & Clinical Development
- Vaccine Surveillance & Epidemiology
- Vaccine Manufacturing & Quality Control
- Vaccine Interactions & Combination Vaccines
- Vaccine Resistance & Escape Mutants
- Vaccine Pharmacovigilance & Post-Marketing Surveillance
- Vaccines Formulation & Bioprocess
Speakers
| Dr. Philip Dormitzer | Senior Vice President and Global Head of Vaccines Research and Development,GSK, USA |
| Patricia Mechael | Senior Associate, Department of International Health, Johns Hopkins Bloomberg School of Public Health, USA |
| Dr. Derek O'Hagan | Senior Advisor Vaccines R&D, GSK, USA |
| Dr. Sabine Hauck | EVP Corporate Development, Leukocare AG, Germany |
| Dr. Denise L Faustman | Director of Immunobiology, Massachusetts General Hospital, USA |
| Dr. Alessandro Sette | Professor and Member, La Jolla Institute for Immunology, Division of Vaccine Discovery, University of California, USA |
| Dr. Christopher Locher | CEO & Co-Founder, Versatope Therapeutics, Inc., USA |
| Dr. Trina Racine | Director - Vaccine Development, Vaccine and Infectious Disease Organization (VIDO), Canada |
| Dr. Mark C Poznansky | Director – Vaccine and Immunotherapy Center (VIC), Massachusetts General Hospital, USA |
| Dr. John Fulkerson | Executive Director, Vaccines and Infectious Diseases, MESOSCALE, USA |
| Dr. Tzachi Pilpel | Professor and Head, Department of Molecular Genetics, Weizmann Institute of Science, Israel |
| Dr. Luigi Buonaguro | Director, Innovative Immunological Models Unit, National Cancer Institute "Pascale", Italy |
| Dr. Prakash Bhuyan | Chief Medical Officer, Aerium Therapeutics, USA |
| Dr. Njoh Andreas Ateke | Deputy Permanent Secretary, Expanded Program on Immunization, Cameroon |
| Dr. Tamir Tuller | Professor, Director of Laboratory of Computational Systems and Synthetic Biology, Tel Aviv University, Israel |
| Dr. Charles Jones | Senior Director, mRNA Commercial Strategy & Innovation, Pfizer, USA |
| Dr. Dan Barouch | Professor of Immunology, Harvard Medical School, USA |
| Juliana Melgaço | Research and development Analyst, FIOCRUZ, Brazil |